Company Filing History:
Years Active: 2006
Title: Innovations of Anand Sistla in Pharmaceutical Formulations
Introduction
Anand Sistla is an accomplished inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical formulations, particularly through his innovative work on indolinone derivatives. His research focuses on developing formulations that can effectively modulate the activity of protein kinases, which are crucial in various biological processes.
Latest Patents
Anand Sistla holds a patent for "Pharmaceutical formulations comprising indolinone derivatives." This invention is directed towards formulations that include 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives. These formulations are designed to modulate the activity of protein kinases, which play a vital role in the treatment of diseases associated with abnormal PK activity. The patent also discloses methods for treating such diseases and the processes for creating these formulations.
Career Highlights
Anand is currently associated with Sugen Incorporated, where he continues to advance his research in pharmaceutical sciences. His work has been instrumental in developing new therapeutic strategies that leverage the unique properties of indolinone derivatives.
Collaborations
Anand has collaborated with notable colleagues, including Ping Gao and Narmada R Shenoy, to further enhance the impact of his research in the pharmaceutical industry.
Conclusion
Anand Sistla's innovative contributions to pharmaceutical formulations highlight the importance of research in developing effective treatments for diseases related to protein kinase activity. His work continues to pave the way for advancements in the field of medicine.